Integration of Care in the Implementation of the Affordable Care Act: Changes in Treatment Services in a National Sample of Centers Treating Substance Use Disorders

References

• Aletraris, L., M. B. Edmond, M. Paino, D. Fields, and P. M. Roman. 2016. Counselor training and attitudes toward pharmacotherapies for opioid use disorder. Substance Abuse 37 (1):47–53. doi:10.1080/08897077.2015.1062457.
   PubMed Web of Science ®Google Scholar
• Aletraris, L., M. B. Edmond, and P. M. Roman. 2015. Adoption of injectable naltrexone in U.S. substance use disorder treatment programs. Journal of Studies on Alcohol and Drugs 76 (1):143–51. doi:10.15288/jsad.2015.76.143.
   PubMed Web of Science ®Google Scholar
• Aletraris, L., and P. M. Roman. 2015. Provision of onsite HIV services in substance use disorder treatment programs: A longitudinal analysis. Journal of Substance Abuse Treatment 57:1–8. doi:10.1016/j.jsat.2015.04.005.
   PubMed Web of Science ®Google Scholar
• Aletraris, L., J. S. Shelton, and P. M. Roman. 2015. Counselor attitudes toward contingency management for substance use disorder: Effectiveness, acceptability and endorsement of incentives for treatment attendance and abstinence. Journal of Substance Abuse Treatment 57:41–48. doi:10.1016/j.jsat.2015.04.012.
   PubMed Web of Science ®Google Scholar
• Babor, T. F., B. G. McRee, P. A. Kassebaum, P. L. Grimaldi, K. Ahmed, and J. Bray. 2007. Screening, Brief Intervention, and Referral to Treatment (SBIRT): Toward a public health approach to the management of substance abuse. Substance Abuse 28 (3):7–10. doi:10.1300/J465v28n03_03.
   PubMedGoogle Scholar
• Barry, C. L., and H. A. Huskamp. 2011. Moving beyond parity—mental health and addiction care under the ACA. New England Journal of Medicine 365 (11):973–75. doi:10.1056/NEJMp1108649.
   PubMed Web of Science ®Google Scholar
• Bride, B. E., Y. J. Choi, I. W. Olin, and P. M. Roman. 2016. Patient violence towards counselors in substance use disorder treatment programs: Prevalence, predictors, and responses. Journal of Substance Abuse Treatment 57:9–17. doi:10.1016/j.jsat.2015.04.004.
   Web of Science ®Google Scholar
• Buck, J. A. 2011. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Affairs 30 (8):1402–10. doi:10.1377/hlthaff.2011.0480.
   PubMed Web of Science ®Google Scholar
• Edmond, M. B., L. Aletraris, M. Paino, and P. M. Roman. 2015. Treatment strategy profiles in substance use disorder treatment programs: A latent class analysis. Drug and Alcohol Dependence 153:109–15. doi:10.1016/j.drugalcdep.2015.05.047.
   PubMed Web of Science ®Google Scholar
• Friedmann, P. D., D. McCollough, M. H. Chin, and R. Saitz. 2000. Screening and intervention for alcohol problems: A national survey of primary care physicians and psychiatrists. Journal of General Internal Medicine 15 (2):84–91. doi:10.1046/j.1525-1497.2000.03379.x.
   PubMed Web of Science ®Google Scholar
• Garfield, R. L., S. H. Zuvekas, J. R. Lave, and J. M. Donohue. 2011. The impact of national health care reform on adults with severe mental disorders. American Journal of Psychiatry 168 (5):486–94. doi:10.1176/appi.ajp.2010.10060792.
   PubMed Web of Science ®Google Scholar
• Henry J. Kaiser Foundation. 2014. Health reform implementation timeline. http://kff.org/interactive/implementation-timeline/ ( accessed December 1, 2016).
   Google Scholar
• Henry J. Kaiser Foundation. 2016. The Affordable Care Act after six years. http://kff.org/health-reform/perspective/the-affordable-care-act-after-six-years/ ( accessed December 1), 2016.
   Google Scholar
• Hutchinson, E., M. Catlin, C. Andrilla, L. Baldwin, and R. Rosenblatt. 2014. Barriers to primary care physicians prescribing buprenorphine. The Annals of Family Medicine 12 (2):128–33. doi:10.1370/afm.1595.
   PubMed Web of Science ®Google Scholar
• Knudsen, H. K. 2015. The supply of physicians waivered to prescribe buprenorphine for opioid use disorders in the United States: A state-level analysis. Journal of Studies on Alcohol and Drugs 76 (4):644–54. doi:10.15288/jsad.2015.76.644.
   PubMed Web of Science ®Google Scholar
• Knudsen, H. K., A. J. Abraham, and C. B. Oser. 2011. Barriers to the implementation of medication-assisted treatment for substance use disorders: The importance of funding policies and medical infrastructure. Evaluation and Program Planning 34:375–81. doi:10.1016/j.evalprogplan.2011.02.004.
   PubMed Web of Science ®Google Scholar
• Knudsen, H. K., and P. M. Roman. 2016. The diffusion of acamprosate for the treatment of alcohol use disorder: Results from a national longitudinal study. Journal of Substance Abuse Treatment 62:62–67. doi:10.1016/j.jsat.2015.10.005.
   PubMed Web of Science ®Google Scholar
• Knudsen, H. K., P. M. Roman, and C. Oser. 2010. Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations. Journal of Addiction Medicine 4:99–107. doi:10.1097/ADM.0b013e3181b41a32.
   PubMed Web of Science ®Google Scholar
• Madras, B. K., W. M. Compton, D. Avula, T. Stegbaur, J. B. Stein, and H. W. Clark. 2009. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: Comparison at intake and 6 months later. Drug and Alcohol Dependence 99 (1–3):280–95. doi:10.1016/j.drugalcdep.2008.08.003.
   PubMed Web of Science ®Google Scholar
• Mark, T. L., K. R. Levit, R. Vandivort-Warren, J. A. Buck, and R. M. Coffey. 2011. Changes in US spending on mental health and substance abuse treatment, 1986–2005, and implications for policy. Health Affairs 30:284–92. doi:10.1377/hlthaff.2010.0765.
   PubMed Web of Science ®Google Scholar
• Mark, T. L., L. M. Wier, K. Malone, M. Penne, and A. J. Cowell. 2015. National estimates of behavioral health conditions and their treatment among adults newly insured under the ACA. Psychiatric Services 66:426–29. doi:10.1176/appi.ps.201400078.
   PubMed Web of Science ®Google Scholar
• McCarty, D., D. Gustafson, V. A. Capoccia, and F. Cotter. 2009. Improving care for the treatment of alcohol and drug disorders. Journal of Behavioral Health Services & Research 36:52–60. doi:10.1007/s11414-008-9108-4.
   PubMed Web of Science ®Google Scholar
• Mee-Lee, D. L., L. Gartner, M. M. Miller, G. D. Shulman, and B. B. Wilford. 1996. Patient placement criteria for the treatment of substance related disorders, 2nd ed. Chevy Chase, MD: American Society of Addiction Medicine.
   Google Scholar
• Polydorou, S., E. W. Gunderson, and F. R. Levin. 2008. Training physicians to treat substance use disorders. Current Psychiatry Reports 10:399–404. doi:10.1007/s11920-008-0064-8.
   PubMedGoogle Scholar
• Rahm, A. K., Boggs, J. M., Martin, C. M., Price, D. W., Beck, A., Backer, T. E., and Dearing, J. W. 2015. Facilitators and barriers to implementing SBIRT in primary care in integrated health care settings. Substance Abuse 36 (3):281-88.
   Google Scholar
• Rogers, E. M. 2003. Diffusion of innovations, 5th ed. New York, NY: The Free Press.
   Google Scholar
• Roman, P. M., A. J. Abraham, and H. K. Knudsen. 2011. Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation. Addictive Behaviors 36:584–89. doi:10.1016/j.addbeh.2011.01.032.
   PubMed Web of Science ®Google Scholar
• Samet, J. H., P. Friedmann, and R. Saitz. 2001. Benefits of linking primary medical care and substance abuse services: Patient, provider, and society perspectives. Archives of Internal Medicine 161 (1):85–91. doi:10.1001/archinte.161.1.85.
   PubMed Web of Science ®Google Scholar
• Saxon, A. J., and D. McCarty. 2005. Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs. Pharmacology and Therapeutics 108:119–28. doi:10.1016/j.pharmthera.2005.06.014.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. 2011. Evidence supporting the effectiveness of an SBIRT. http://www.samhsa.gov/sites/default/files/sbirtwhitepaper_0.pdf
   Google Scholar
• Tai, B., and N. D. Volkow. 2013. Treatment for substance use disorder: Opportunities and challenges under the Affordable Care Act. Social Work in Public Health 28:165–74. doi:10.1080/19371918.2013.758975.
   PubMed Web of Science ®Google Scholar
• Terry-McElrath, Y. M., J. F. Chriqui, and D. C. McBride. 2011. Factors related to Medicaid payment acceptance at outpatient substance abuse treatment programs. Health Services Research 46:632–53. doi:10.1111/hesr.2011.46.issue-2.
   PubMed Web of Science ®Google Scholar
• Thomas, C. P., S. S. Wallack, S. Lee, D. McCarty, and R. Swift. 2003. Research to practice: Adoption of naltrexone in alcoholism treatment. Journal of Substance Abuse Treatment 24:1–11. doi:10.1016/S0740-5472(02)00319-7.
   PubMed Web of Science ®Google Scholar
• Urada, D., C. Teruya, L. Gelberg, and R. Rawson. 2014. Integration of substance use disorder services with primary care: Health center surveys and qualitative interviews. Substance Abuse Treatment, Prevention, and Policy 9:15. doi:10.1186/1747-597X-9-15.
   PubMed Web of Science ®Google Scholar
• Weisner, C., J. Mertens, A. Parthasarathy, C. Moore, and Y. Lu. 2001. Integrating primary medical care with addiction treatment: A randomized controlled trial. Journal of the American Medical Association 286 (14):1715–23. doi:10.1001/jama.286.14.1715.
   PubMed Web of Science ®Google Scholar
• Woodward, A. 2015. The CBHSQ report: The substance abuse prevention and treatment block grant is still important even with the expansion of Medicaid. Rockville, MD: Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality.
   Google Scholar
• World Health Organization. 2008. The effectiveness of a brief intervention for illicit drugs linked to the Alcohol, Smoking, and Substance Involvement Screening test (ASSIST) in primary health care settings: A technical report of phase III findings of the WHO ASSIST randomized control trial. http://www.who.int/substance_abuse/activities/assist_technicalreport_phase3_final.pdf
   Google Scholar